Target intelligence / Profile preview

Chromosome 11 open reading frame 42 (C11orf42)

Target
C11orf42
Molecular classification
Other (DUF4463 domain of unknown function), Potentially related to gasdermin (GSDM) superfamily based on structural bioinformatics, but lacks canonical membrane-pore-forming features
01

Overview

C11orf42 is an uncharacterized, proline-rich protein of 333 amino acids, encoded by a gene spanning 11p15.4. The main sequence features are a domain of unknown function (DUF4463) and a proline-rich region. It is expressed broadly across tissues, including skin, testis, bladder, and brain, with highest levels in testes and thyroid tumors[1][2][5][6]. Structural analysis suggests partial homology to gasdermin proteins, but unlike canonical gasdermins, C11orf42 lacks membrane-penetrating features and thus may not form membrane pores; its putative role has been postulated as a scaffold involved in protein-protein interactions[2][5]. Its clinical significance is not fully understood, but correlations exist between C11orf42 expression and tumor proliferation, prevalence of bladder carcinoma, and modulation of brain aneurysm wall strength[1][2][5]. It interacts with the sorting nexins SNX2 and SNX5, which are involved in growth factor receptor stabilization[3], and IGLL1 via text-mining. There are no known drugs or diagnostic biomarkers targeting C11orf42, and it is not currently considered a therapeutic target[6]. Overall, C11orf42 represents an evolutionarily conserved, structurally intriguing protein with possible—but as yet unconfirmed—roles in cancer biology and vascular disease. Current annotation remains incomplete and largely predictive[1][2][5][6].

Other names
Uncharacterized protein C11orf42MGC34805
02

Biological functions

OtherMay act as a scaffold or structural protein based on predicted similarity to GSDM foldSuggested involvement in transcriptional regulation affecting mechanical strength of aneurysm wallsNo experimentally validated functions
03

Disease associations

Cancer (expression linked to fitness and proliferation in lymphoma, glioblastoma, leukemia cell lines)Bladder carcinoma (expression in tumor tissue)Brain aneurysm (expression pattern correlated with aneurysm wall strengthening)Rheumatoid arthritis (expression possibly modulating response to anti-TNF therapy)Other (no direct causality established)

Beyond the preview

Go deeper on Chromosome 11 open reading frame 42 (C11orf42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 11 open reading frame 42 (C11orf42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call